Study: New GSK vaccine reduces ear infections

03/4/2006 | HealthDay News

Czech researchers say their study of GlaxoSmithKline's new vaccine for ear infections found it reduced problems by one-third among children who received it. Containing proteins from 11 different strains of the bacterium Streptococcus pneumoniae that also are attached to a protein from the infectious agent Haemophilus influenzae, the vaccine is said to protect against the two main causes of middle-ear infection.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC